Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments.

Autor:	Colman BD; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia blake.colman@monash.edu.; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia., Boonstra F; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia., Nguyen MN; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia., Raviskanthan S; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia., Sumithran P; Department of Surgery, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.; Department of Endocrinology, Alfred Hospital, Melbourne, Victoria, Australia., White O; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.; Department of Neuroscience, Monash University Central Clinical School, Clayton, Victoria, Australia., Hutton EJ; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia., Fielding J; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia., van der Walt A; Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.; Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.
Jazyk:	angličtina
Zdroj:	Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Mar 13; Vol. 95 (4), pp. 375-383. Date of Electronic Publication: 2024 Mar 13.
DOI:	10.1136/jnnp-2023-332222
Abstrakt:	Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with headaches, visual abnormalities, tinnitus and cognitive dysfunction. Raised intracranial pressure without a secondary identified cause remains a key diagnostic feature of this condition, however, the underlying pathophysiological mechanisms that drive this increase are poorly understood. Previous theories have focused on cerebrospinal fluid (CSF) hypersecretion or impaired reabsorption, however, the recent characterisation of the glymphatic system in many other neurological conditions necessitates a re-evaluation of these hypotheses. Further, the impact of metabolic dysfunction and hormonal dysregulation in this population group must also be considered. Given the emerging evidence, it is likely that IIH is triggered by the interaction of multiple aetiological factors that ultimately results in the disruption of CSF dynamics. This review aims to provide a comprehensive update on the current theories regarding the pathogenesis of IIH. Competing Interests: Competing interests: PS has co-authored manuscripts with medical writing provided by Novo Nordisk and Eli Lilly. She is supported by an Investigator Grant from the National Health and Medical Research Council (1178482). JF receives funding from Genzyme and Biogen and has received honorarium from Novartis. AvdW has received travel support and served on advisory boards for Novartis, Biogen, Merck Serono, Roche and Teva. She receives grant support from the National Health and Medical Research Council of Australia and MS Research Australia. (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu